107.21MMarket Cap-349P/E (TTM)
0.540High0.500Low791.45KVolume0.521Open0.518Pre Close413.55KTurnover0.46%Turnover RatioLossP/E (Static)207.50MShares1.67052wk High1.29P/B88.39MFloat Cap0.29152wk Low--Dividend TTM171.07MShs Float51.375Historical High--Div YieldTTM7.71%Amplitude0.291Historical Low0.522Avg Price1Lot Size
Sangamo Therapeutics Stock Forum
Anxious to see data!
One of these days soon you will get the attention you so much deserve!
Sangamo Therapeutics expected to release the good news on FDA approval.
And the trend continues up
Looking good here!
Update
Benzinga· 2 mins ago
- U.S. Food and Drug Administration (FDA) advises that a single study with up to 25 patients, in combination with confirmatory evidence, may be acceptable pathway to Biologics License Application (BLA) submission for isaralgagene civaparvovec, which would significantly reduce anticipated complexi...
No comment yet